tiprankstipranks
Trending News
More News >
22nd Century (XXII)
NASDAQ:XXII

22nd Century (XXII) Price & Analysis

Compare
1,735 Followers

XXII Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

21.13%<0.01%2.71%76.15%
21.13% Insiders
2.71% Other Institutional Investors
76.15% Public Companies and Individual Investors

XXII FAQ

What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $0.64 and its highest was $126.09 in the past 12 months.
    What is 22nd Century’s market cap?
    22nd Century’s market cap is $4.91M.
      When is 22nd Century’s upcoming earnings report date?
      22nd Century’s upcoming earnings report date is Aug 06, 2025 which is in 50 days.
        How were 22nd Century’s earnings last quarter?
        22nd Century released its earnings results on May 13, 2025. The company reported -$1.89 earnings per share for the quarter, missing the consensus estimate of -$1.1 by -$0.79.
          Is 22nd Century overvalued?
          According to Wall Street analysts 22nd Century’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does 22nd Century pay dividends?
            22nd Century does not currently pay dividends.
            What is 22nd Century’s EPS estimate?
            22nd Century’s EPS estimate is -0.27.
              How many shares outstanding does 22nd Century have?
              22nd Century has 7,605,807 shares outstanding.
                What happened to 22nd Century’s price movement after its last earnings report?
                22nd Century reported an EPS of -$1.89 in its last earnings report, missing expectations of -$1.1. Following the earnings report the stock price went up 7.477%.
                  Which hedge fund is a major shareholder of 22nd Century?
                  Among the largest hedge funds holding 22nd Century’s share is GMT Capital Corp. It holds 22nd Century’s shares valued at 0.

                    Company Description

                    22nd Century

                    22nd Century Group, Inc. (XXII) is a biotechnology company focused on developing and commercializing reduced nicotine tobacco and hemp/cannabis plant products. The company operates in the sectors of plant biotechnology and consumer products, with core offerings that include proprietary tobacco plants engineered for reduced nicotine content, as well as hemp and cannabis plants with optimized cannabinoid profiles. Their mission is to reduce the harm associated with smoking and to advance the science of cannabinoids.

                    XXII Earnings Call

                    Q1 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call reflects significant progress in revenue growth and operational efficiency, supported by strategic product launches and successful capital raising. However, ongoing challenges in achieving positive gross margins and net profitability, along with share dilution, present areas of concern.Read More>
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Universal
                    Turning Point Brands
                    Greenlane Holdings
                    Kaival Brands Innovations Group
                    Ispire Technology, Inc.
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis